InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,951.20
(
0.53%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.40
(
-0.02%
)
Bitcoin
56,629.00
(
-0.14%
)
Post# of 252525
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 119992
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Wednesday, 10/12/2016 12:06:15 PM

Wednesday, October 12, 2016 12:06:15 PM

Post# of 252525
AZRX IPOs 1.1M* shares @$5.50:

http://finance.yahoo.com/news/azurrx-biopharma-announces-pricing-initial-120000106.html

AzurRx BioPharma, Inc. aims to become a leader in developing non-systemic, recombinant protein therapies for the treatment of gastrointestinal diseases and related conditions. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company’s lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infection. The company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France.

Does it make sense to conduct an IPO that raises only $6M?

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up